Q1 2025 Gerresheimer AG Earnings Call Transcript

Apr 11, 2025 / 08:00AM GMT

Key Points

Positve
  • Gerresheimer AG (GRRMF) reported a significant revenue increase due to the acquisition of Bormioli Pharma, marking the largest acquisition in the company's history.
  • The integration of Bormioli Pharma is expected to create a global moulded glass powerhouse, enhancing Gerresheimer's position in the pharma and biotech industry.
  • The company projects sustainable profitable growth of 8% to 10% in the midterm, supported by new product lines and a shift to high-value products.
  • Gerresheimer AG (GRRMF) is making significant investments in eco-friendly technology, such as the new hybrid furnace in Lohr, Germany, which reduces carbon emissions by 40%.
  • The company has a strong order book and expects to return to organic growth from Q2 onwards, supporting its 2025 guidance.
Negative
  • Gerresheimer AG (GRRMF) experienced an organic revenue decline of 6.5% and an EBITDA decline of 9.3% in Q1 2025.
  • The company faced softer demand in its moulded glass business, particularly in the cosmetics market.
  • The Morganton facility in the US is still recovering from flooding, impacting production capacity.
  • The adjusted EPS declined by 36.6% on an FX-neutral basis, reflecting challenges in the current financial environment.
  • Free cash flow was negative in Q1, and the company expects to end the year with a free cash flow figure between minus EUR50 million and 0.
Operator

Ladies and gentlemen, welcome to the publication Q1 2025 results conference call. I am George, the chorus call operator. (Operator Instructions) And the conference is being recorded.

(Operator Instructions) At this time, it's my pleasure to hand over to Mr. Guido Pickert, Vice President, Corporate Investor Relations. Please go ahead.

Guido Pickert
Gerresheimer AG - Vice President - Corporate Investor Relations

Thank you very much. We welcome you to our Q1 2025 results call presentation, which will be hosted by our CEO, Dietmar Siemssen and our CFO, Dr. Bernd Metzner.

For the start, I would like -- our CEO to start the presentation, Dietmar.

Dietmar Siemssen
Gerresheimer AG - Chairman of the Management Board, Chief Executive Officer

Yeah, welcome everybody. And thank you for joining us this morning. I will start by giving you an overview of our business performance and main influence of the first quarter. Then Bernd Metzner our CFO will take you into a deep dive into the numbers. As always, we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot